Filtering by:
Chronic Lymphocytic Leukemia (CLL)Slideshow: COVID-19 Pandemic Affects the Cancer Continuum
ACS 2021 studies show how COVID-19 is affecting prevention efforts, expected cancer screening rates, treatment, quality-of-life, and research.
FDA Approves Lumoxiti (Moxetumomab Pasudotox) for Hairy Cell Leukemia
The US Food and Drug Administration (FDA) has approved Lumoxiti (moxetumomab pasudotox-tdfk) for adults with hairy cell leukemia (HCL) that did not get better with at least 2 different previous treatments or got better but then came back.
Leukemia Survivor: ‘Every Day is a Day of Hope’
Barbara Borrell’s health problems began the day she was born in 1942 when she was diagnosed with diabetes. For the next 50 years she made nutrition and exercise a priority. But in 1993, she was diagnosed with chronic lymphocytic leukemia.
FDA Approves Venclexta (Venetoclax) for a Type of Chronic Lymphocytic Leukemia
The US Food and Drug Administration (FDA) has approved a new targeted therapy for a certain type of chronic lymphocytic leukemia (CLL).